This page is marked NOINDEX and hidden from search engines: fails the stub criteria, missing: investor relationships, two agreeing sources.

Kaigene Form D (2026)

Kaigene reported $54,958,229 raised in an SEC Form D filed on 2026-10-14.

Company
Kaigene
Round type
Form D
Date
2026-10-14
Amount
$54.96M
Industry
Biotechnology
Location
Maryland

Summary

The SEC Form D for Kaigene, filed on 2026-10-14, reports $54,958,229 raised. It was listed in the Raise Track Update of 2026-10-15. Filing: https://www.sec.gov/Archives/edgar/data/1919055/000191905526000004/0001919055-26-000004-index.htm

This page is not indexed by search engines yet because the filing is its only source.

Investors

Sources

Last verified:

  1. https://www.sec.gov/Archives/edgar/data/1919055/000191905526000004/0001919055-26-000004-index.htm
    Type: sec filing. Accessed 2026-10-15.
    SEC Form D for Kaigene, Inc. EDGAR filing date 2026-10-14. Signed 2026-10-14. First sale 2026-09-30. Total amount sold $54,958,229 of an offering amount of $73,350,000. 22 investors already invested. Issuer address city is Rockville, Maryland. Jurisdiction of incorporation is Delaware. The form does not name those investors or a round type. Street addresses are not published.
  2. https://buttondown.com/raisetrack/archive/raise-track-update-2026-10-15/
    Type: other verified public source. Accessed 2026-10-15.
    Raise Track Update for 2026-10-15, Section 3 (SEC Form D filings). Lists Kaigene, state MARYLAND, industry Biotechnology, amount raised $54,958,229.